Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 29,888 ERAS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Erasca, Inc. (ERAS) | Grant/Award | 29,888 | n/a |
| Jun 26, 2025 | Erasca, Inc. (ERAS) | Grant/Award | 120,000 | n/a |
| Jul 29, 2024 | IGM Biosciences, Inc. (IGMS) | Exercise/Conversion | 15,132 | $21.0K |
| Jun 21, 2024 | Erasca, Inc. (ERAS) | Grant/Award | 60,000 | n/a |
| Jun 5, 2024 | SpringWorks Therapeutics, Inc. (SWTX) | Sale | 2,946 | $116.1K |
| May 17, 2024 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/Award | 4,095 | n/a |
| Mar 14, 2024 | IGM Biosciences, Inc. (IGMS) | Grant/Award | 29,400 | n/a |
| Jun 26, 2023 | Erasca, Inc. (ERAS) | Grant/Award | 60,000 | n/a |
| Jun 24, 2022 | Erasca, Inc. (ERAS) | Grant/Award | 40,000 | n/a |
| Jul 21, 2021 | Erasca, Inc. (ERAS) | Purchase | 6,000 | $96.0K |